Mr. Speaker, the answer is zero deliveries.
I would like to hear him tell Quebec seniors that these delays are a good thing.
On January 21, Global News reminded us that Pfizer had asked the finance committee for improvements to the corporate tax regime, tax incentives for the industry and changes to drug pricing procedures in Canada.
Is the Prime Minister at all concerned about the fact that, even as Pfizer is delaying and cancelling deliveries, it is asking Canada's finance department for more favourable treatment?